Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Haselmeier - Self-Injection Devices White Papers

Haselmeier - Self-Injection Devices

Biocon Launches Haselmeier's Insulin Pen in India Haselmeier has announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen® in India. Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen, for use with Biocon's insulin and insulin analogues. The first launch of the INSUPen has taken place with Biocon's Basalog® and Insugen® insulins.
View white paper
Haselmeier Establishes New Pen Injector Assembly Facility in India Haselmeier, a leading designer and manufacturer of pen injection systems, announced that it will establish a new manufacturing facility in Bangalore, India to produce and supply high-quality, competitively priced pen injectors for the pharmaceutical industry in India. The reusable and easy-to-use pen is based on the i-pen technology and designed to allow accurate and reliable dosing.
View white paper
First Application of Haselmeier's Axis-D Injection Pen in Launched Haselmeier has announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck KGaA, Germany, the new injection device has been designed to allow self injection by patients of a ready to use biopharmaceutical solution for injection.
View white paper